Abaloparatide is a parathyroid hormone-related peptide analog used to treat osteoporosis in postmenopausal women at high risk for fracture. It stimulates bone formation by activating the PTH1 receptor. Abaloparatide is administered as a daily subcutaneous injection. It is typically limited to a 2-year treatment duration.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Abaloparatide and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Abaloparatide impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Abaloparatide-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
